Research Article
Clinical Utility of Serum Holotranscobalamin Measurements in Patients with First-Ever Ischemic Stroke
Table 1
Characteristics of the first-ever stroke patients in this study.
| Characteristics | Patients with ischemic stroke () |
| Age, median years [Q1–Q3] | 71 [59–78] | Sex, % male () | 62.3 (81) | Clinical presentations, % () | | Hemiparesis/hemiplegia/weakness | | Left | 31.5 (41) | Right | 16.2 (21) | Bilateral | 1.5 (2) | Dysarthria | 27.7 (36) | Dizziness | 16.2 (21) | Mental change | 10.0 (13) | Amnesia | 1.5 (2) | Involved brain region, % () | | Frontal lobe | 23.1 (30) | Temporal lobe | 22.3 (29) | Parietal lobe | 16.2 (21) | Occipital lobe | 12.3 (16) | Basal ganglia | 14.6 (19) | Corona radiata | 13.8 (18) | Pons | 13.1 (17) | Cerebellum | 17.7 (23) | Brain atrophy, % () | 6.9 (9) | NIHSS, median [Q1–Q3] | 2 [1–5.25] | mRS, median [Q1–Q3] | 4 [2–4] |
|
|
Abbreviations: NIHSS: National Institute of Health Stroke Scale; mRS: modified Rankin Scale.
|